Healthcare - Biotechnology - NASDAQ - US
$ 8.01
-8.98 %
$ 445 M
Market Cap
-4.77
P/E
Price Target
Average
90.83%
Revenue Forecast
Estimate
42.14%
EBIT
Estimate
6.17%
Net Income
Estimate
22.52%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Foghorn Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for FHTX of $15.3 , with forecasts ranging from a low of $9 to a high of $20 .
FHTX Lowest Price Target
Wall Street Target
9 USD
12.36%
FHTX Average Price Target
Wall Street Target
15.3 USD
90.83%
FHTX Highest Price Target
Wall Street Target
20 USD
149.69%
REVENUE FORECAST
Revenue Forecast Chart FHTX
EBIT FORECAST
EBIT Forecast Chart FHTX
NET INCOME FORECAST
Net Income Chart FHTX